0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessPoster: 2018 ASM / R-0117 / The RAPPORT clinical trial: interim safety analysis of combination SABR with adjuvant anti-PD1 immunotherapy in oligometastatic renal cell carcinoma by: Siva1, M. Bressel1, M. Shaw1, S. Chander1, S. Loi1, D. Pryor2, S. Sandhu1, J. Mooi1, D. Jayamanne3, T. Eade3, N. Lawrentschuk 1, D. Murphy1, J. Lewin1, B. Tran1, F. Foroudi1; 1VIC/AU, 2QLD/AU, 3NSW/AU
Shankar Siva, Mathias Bressel, Mark Shaw, Sarat Chander, Sherene Loi, David Pryor, Shahneen Sandhu, Jennifer Mooi, Dasantha Jayamanne, Thomas Eade, Nathan Lawrentschuk, Declan Murphy, Jeremy Lewin, Ben Tran, Farshad Foroudi (2018). The RAPPORT clinical trial: interim safety analysis of combination SABR with adjuvant anti-PD1 immunotherapy in oligometastatic renal cell carcinoma.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2018
Authors
15
Datasets
0
Total Files
0
Language
en
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
